3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
2
Leukemia, Myeloid, Acute
2
Triple Negative Breast Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Motor Activity
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Blast Crisis
1
Interventions
Social Determinants of Health
2
Electrocardiography
2
Echocardiography
2
zanubrutinib
1
sofosbuvir-velpatasvir drug combination
1
acalabrutinib
1
Vascular Stiffness
1
Standard of Care
1
Restraint, Physical
1
Referral and Consultation
1
Quality of Life
1
Pulse Wave Analysis
1
Practice Guidelines as Topic
1
Positron-Emission Tomography
1
Physical Conditioning, Human
1
Patient Navigation
1
Nutrition Assessment
1
Methods
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Hematologic Tests
1
Health Information Exchange
1
Geritol
1
Fish Oils
1
Fatty Acids, Omega-3
1
Ethanol
1
Educational Status
1
Early Intervention, Educational
1
Diet, Mediterranean
1
Cholecalciferol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiovascular Diseases
×
Geritol
×
1 year
×
Clear all
NCT02422745
2025-09-24
COSMOS
Brigham and Women's Hospital
Phase 4
Completed
21,442 enrolled
31 charts